Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-27 to 2023-06-28
Current total value of award: $26500.6
Description: 4561355909!NUCALA 100 MG/ML SYRINGEML